Art Krieg, MD- OTS Webinar
Categories: Past WebinarsPublished On: April 26th, 2023


Art Krieg, MD- OTS Webinar

Time: 8AM PST | 11AM EST | 5PM CET
Date: June 8, 2023

Starting from the concept and principles of Nucleic Acid Immunity, I will explain why TLR7 and TLR9 are unique among the nucleic acid immune sensing receptors for their ability to activate IFN-a secretion from plasmacytoid dendritic cells, and how their agonists can be used to activate innate immunity to optimize cancer immunotherapy.

What is your research about?
Developing a CpG-A DNA agonist for TLR9 in a virus-like particle for cancer immunotherapy


Art Krieg, MD
Adjunct Professor
University of Massachusetts
Chan Medical School RNA Therapeutics Institute